Kaye Randall
- SEC CIK
- 0001350416
No open-market purchases or sales filed in the past year.
Current role at each company
- LBPH Longboard Pharmaceuticals, Inc.Executive Vice President & CMOas of Dec 2, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kaye Randall as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2024 (view filing) | Oct 15 | 1 day | Kaye RandallCMO | SSale | −16.7K | $59.04 | −$984.0K | −48.2%17.9K after | 10b5-1 |
| Sep 16, 2024 (view filing) | Sep 16 | Same day | Kaye RandallCMO | SSale | −16.7K | $31.64 | −$527.3K | −48.2%17.9K after | 4 lots10b5-1 |
| Aug 13, 2024 (view filing) | Jan 23 | 203 daysLate | Kaye RandallCMO | PPurchase | +100 | $24.82 | +$2.48K | New position100 after | 10b5-1 |
| Aug 13, 2024 (view filing) | Jun 25 | 49 daysLate | Kaye RandallCMO | SSale | −100 | $20.87 | −$2.09K | −100.0%0 after | 10b5-1 |
| Aug 13, 2024 (view filing) | Aug 12 | 1 day | Kaye RandallCMO | SSale | −16.7K | $34.73 | −$578.8K | −48.2%17.9K after | 2 lots10b5-1 |